Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi

Importance: The protective efficacy of COVID-19 vaccinations has declined over time such that booster doses are required. Objective: To evaluate the efficacy and adverse events of booster doses of two inactivated COVID-19 vaccines. Design: This is a double-blind, randomized, placebo-controlled phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Kaabi, Nawal, Yang, Yunkai, Eldin Hussein, Salah, Yang, Tian, Abdalla, Jehad, Wang, Hui, Lou, Zhiyong, Bakkour, Agyad, Arafat, Afnan, Jiang, Zhiwei, Tian, Ye, Xiao, Peng, Zaher, Walid, Eltantawy, Islam, Wang, Chenlong, Xu, Guangxue, Zhang, Yuntao, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962595/
https://www.ncbi.nlm.nih.gov/pubmed/36851177
http://dx.doi.org/10.3390/vaccines11020299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962595/
https://www.ncbi.nlm.nih.gov/pubmed/36851177
http://dx.doi.org/10.3390/vaccines11020299

Ejemplares similares